Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 March 2018 Photo Leonie Bolleurs
Second triumph for young pollution and pharmaceutical researcher
Emmie Chiyindiko, winner of Famelab.

“I am grateful to be reaping the benefits of stepping out of my comfort zone. By facing the unfamiliar, that challenge will allow me to see what great things I am capable of,” said Emmie Chiyindiko, winner of Famelab 2018.

With FameLab, the world’s leading science communication competition, participants have just three minutes to win over the judges and crowd with a scientific talk that excels in content, clarity and charisma. Contestants from around the world participate, armed only with their wits and a few props.

Emmie won the Postgraduate School’s Three-Minute-Thesis competition for master’s level in 2017.

She said: “My research is based on the synthesis and characterisation of a series of unique metal complexes.” These complexes are used both as active pharmaceutical ingredients and cosmetic additives to reduce the detrimental effects of UV radiation on the skin. They are incorporated into anti-ulcer, gastro protective drugs, anti-asthmatic, lung disease drugs, with anti-cancer and anti-diabetic agents,” she said.

With her research she can also monitor air pollution. Formaldehyde is a known toxin to human health. “Using metal complexes, I am able to monitor the production of formaldehyde and consequently come up with exposure prevention methods,” said Emmie.

She believes that it is okay to not ”fit in“. “Mannerisms such as your quirks make you different and distinctive. Live your life intentionally, imprint your personal mark on this universe and always choose faith over fear.”

News Archive

Student’s study accepted in top anti-microbiotic journal
2008-10-28

 

Part of the study of Ruan Els, 'n M.Sc. student at the University of the Free State’s (UFS) Department of Microbial, Biochemical and Food Biotechnology was recently accepted for publication in one of the top anti-microbiotic journals, "Journal of Antimicrobial Chemotherapy". With this he became the first M.Sc. student at the UFS whose research as first author is published in such a high-impact journal. The part that was published is about a possible way of improving the functioning of drugs that kill fungi which cause diseases in humans. By combining the drug with a fatty acid, less of the drugs that can sometimes be poisonous to humans, can be added to kill the fungus. Here he is with his study leader, Dr Carlien Pohl.
Photo: Lacea Loader

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept